Delivery Order SPE2DB24D3014-SPE2DB25FKTGM

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,436.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Lantus Solostar 100 unit/ml 3ml, a specialty medication used for diabetes management. The contract has an ultimate completion date of May 16, 2024 and is a firm fixed-price arrangement. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,734.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of February 9, 2024, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,098.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a diabetes medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC enables Amerisourcebergen to supply a wide range of...
This federal contract award, with a value of $1,384.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used for the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award, valued at $1,197.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB25D3017|SPE2DB25FVHTB) for the supply of Lantus Solostar 100 unit/ml 3ml, a diabetes medication. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,823.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a pharmaceutical product commonly used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. The contract is not designated as a set-aside and was awarded under an...
This federal contract award, valued at $2,592.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,997,716 units of Lantus Solostar 100 unit/mL 3mL, a prescription medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has an ultimate completion date of March 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,406.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for DLA Troop Support Medical to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,231.96 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, which is a medication commonly used to treat diabetes. The contract has an ultimate completion date of November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKTGM
    Delivery Order

This federal contract award, valued at $1,129.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA Troop Support Medical program through December 2026. This IDC enables AmerisourceBergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:15 AM